Systematic Lupus Erythematosus: Epidemiology and Patient-Based Market Forecasts, Treatment Algorithm, and Marketed and Pipeline Drug Analysis

  • ID: 3797463
  • Drug Pipelines
  • 190 pages
  • Datamonitor Healthcare
1 of 3
A shift in the systemic lupus erythematosus (SLE) market is forecast over the next 10 years, as new product approvals drive a movement from traditional off-label treatment to prescribing of approved therapies.

This report addresses the following questions:

- How has the approval of Benlysta impacted the treatment algorithm and clinical trial design?
- What will drive growth in the SLE market over the next 10 years, and which patient groups will be most impacted by new product launches?
- What factors have led to the late-phase clinical trial failures that continue to be seen in SLE?
- Which clinical attributes will a new drug need to demonstrate in order to compete in this market?
Note: Product cover images may vary from those shown
2 of 3
FORECAST: SYSTEMIC LUPUS ERYTHEMATOSUS

- Executive Summary
- Market Overview and Trends
- Market Definition and Methodology
- anifrolumab
- Benlysta SLE (belimumab)
- blisibimod
- Primary Research Methodology

EPIDEMIOLOGY: SYSTEMIC LUPUS ERYTHEMATOSUS

- Executive Summary
- Sources and Methodology,
- Forecast,
- Epidemiologist Insight,
- Strengths and Limitations

MARKETED DRUGS: SYSTEMIC LUPUS ERYTHEMATOSUS

- Executive Summary,
- Product Overview,
- Primary Research Methodology,
- Product profile: Benlysta,
- Product profile: Off-label: CellCept,
- Product profile: Off-label: Rituxan

PIPELINE: SYSTEMIC LUPUS ERYTHEMATOSUS

- Executive Summary
- Clinical Pipeline Overview
- Comparator Therapy
- Clinical Trial Design
- The Future of Disease Treatment
- Recently Discontinued Drugs
- Primary Research Methodology
- Product profile (late stage): Lupuzor
- Product profile (late stage): anifrolumab
- Product profile (late stage): atacicept
- Product profile (late stage): blisibimod
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll